TESTDNA To Sell ColoAlert For Mainz Biomed In Poland
The ColoAlert test helps find colorectal cancer early. It can identify cancer sooner. Anatomy Image made a photo on Shutterstock.com.
Mainz Biomed and TESTDNA have teamed up for the ColoAlert test in Poland.
The company Mainz Biomed created ColoAlert to find colorectal cancer at home. They will partner with another company to market the test in Poland. They will work on plans to sell the test in the upcoming weeks.
Darin Leigh, the chief commercial officer of Mainz Biomed, stated that entering Poland is a big deal for the company. Mainz Biomed is excited to partner with TESTDNA to establish ColoAlert commercially in Poland.
We have a new lab partner called TESTDNA. They want to help prevent deadly diseases like CRC, which is the second most deadly cancer in Europe. It's good news for our growing network of partners. They provide diagnostic screening tools to help patients survive.
ColoAlert is a test that can help find colorectal cancer early. It's a painless test. ColoAlert can find cancer better than other tests like the faecal occult blood test.
This test finds more cases of colorectal cancer than other stool tests. It uses polymerase chain reaction technology.
This test is sold in some EU countries through company health plans, direct sales, and independent labs.
Additionally, the exam will be evaluated in a Crucial US research named ReconAAsense.
